Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Tenofovir on Intracellular and Plasma Levels of Abacavir and Lamivudine in HIV-Infected Patients
2004-000948-25Phase 4Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tenofovir disoproxil fumarate, abacavir and lamivudine in human immunodeficiency virus infection (HIV), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoints: Change in intracellular lamivudine levels and Change in intracellular abacavir levels. Started Sep 2004; status: completed.
02
Drugs
tenofovir disoproxil fumarateabacavirlamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-000948-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000948-25.